Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
出版年份 2020 全文链接
标题
Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-07-16
DOI
10.3389/fonc.2020.01115
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
- (2019) Cristina Raimondi et al. Cancers
- P-089FOLFIRI plus panitumumab as second-line treatment in mutated RAS metastatic colorectal cancer patients who converted to wild type RAS after receiving first-line FOLFOX/CAPOX plus bevacizumab-based treatment: Phase II CONVERTIX trial
- (2019) A Fernández Montes et al. ANNALS OF ONCOLOGY
- Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer
- (2019) Emilie Moati et al. INTERNATIONAL JOURNAL OF CANCER
- Multiclonal tumor origin: Evidence and implications
- (2018) Barbara L. Parsons MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Significance of Liquid Biopsy for Monitoring and Therapy Decision of Colorectal Cancer
- (2018) Susanne Klein-Scory et al. Translational Oncology
- Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy)
- (2018) Jessica Garcia et al. Oncotarget
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial
- (2018) Khurum H. Khan et al. Cancer Discovery
- 543PGene mutation status in circulating tumor DNA (ctDNA) and first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) harboring RAS mutation
- (2018) Y Sunakawa et al. ANNALS OF ONCOLOGY
- Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
- (2018) Jesús García-Foncillas et al. BRITISH JOURNAL OF CANCER
- Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan
- (2018) Chiara Cremolini et al. JAMA Oncology
- The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
- (2017) Julian Walter Holch et al. EUROPEAN JOURNAL OF CANCER
- Optimization of RAS/BRAF Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer
- (2017) Cristina Santos et al. MOLECULAR CANCER THERAPEUTICS
- Blood-based detection ofRASmutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-basedRAStesting
- (2017) Wolff Schmiegel et al. Molecular Oncology
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres
- (2016) Annemarie Boleij et al. BMC CANCER
- Utility ofKRASmutation detection using circulating cell-free DNA from patients with colorectal cancer
- (2016) Takeshi Yamada et al. CANCER SCIENCE
- A Study of Hypermethylated Circulating Tumor DNA as a Universal Colorectal Cancer Biomarker
- (2016) S. Garrigou et al. CLINICAL CHEMISTRY
- Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
- (2016) John M. Findlay et al. Nature Communications
- Kirsten Ras* oncogene: Significance of its discovery in human cancer research
- (2016) Nobuo Tsuchida et al. Oncotarget
- Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab
- (2016) Rodrigo A. Toledo et al. Oncotarget
- Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment
- (2015) M. P. Morelli et al. ANNALS OF ONCOLOGY
- MethyLight droplet digital PCR for detection and absolute quantification of infrequently methylated alleles
- (2015) Ming Yu et al. Epigenetics
- Metastatic Colorectal Cancer: Current State and Future Directions
- (2015) Marwan G. Fakih JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment andRASMutations in Colorectal Cancer
- (2015) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution
- (2015) Shaoping Ling et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Relevance of KRAS-Mutated Subclones Detected with Picodroplet Digital PCR in Advanced Colorectal Cancer Treated with Anti-EGFR Therapy
- (2014) P. Laurent-Puig et al. CLINICAL CANCER RESEARCH
- Changes in mutational status during third-line treatment for metastatic colorectal cancer-Results of consecutive measurement of cell free DNA,KRASandBRAFin the plasma
- (2014) Karen-Lise Garm Spindler et al. INTERNATIONAL JOURNAL OF CANCER
- Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer
- (2013) Jean-Pierre Roperch et al. BMC CANCER
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- A Comprehensive Survey of Ras Mutations in Cancer
- (2012) I. A. Prior et al. CANCER RESEARCH
- Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon
- (2008) Kevin M Haigis et al. NATURE GENETICS
- DNA methylation analysis by digital bisulfite genomic sequencing and digital MethyLight
- (2008) D. J. Weisenberger et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started